Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

LONDON BRIEFING: L&G upbeat on earnings; AstraZeneca wins approvals

16th Nov 2026 07:57

(Alliance News) - Legal & General expects full-year earnings growth to exceed its target range following positive third-quarter trading, while Coca-Cola HBC secures approval for a secondary listing in Johannesburg ahead of its Coca-Cola Beverages Africa acquisition. AstraZeneca receives US approval for its Imfinzi bladder cancer treatment and US and EU approvals for Klygefa.

Here is what you need to know before the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.2% at 10,919.06

GBP: lower at USD1.3209 (USD1.3219 at previous London equities close)

----------

BROKER RATINGS

----------

Deutsche Bank Research raises Croda International to 'buy' (hold) - price target 4,100 (3,300) pence

----------

Jefferies cuts Bellway to 'hold' (buy) - price target 2,472 (2,527) pence

----------

Jefferies raises Travis Perkins to 'hold' (underperform) - price target 618 (453) pence

----------

COMPANIES - FTSE 100

----------

Legal & General says it remains on track to meet or exceed its strategic targets, with core operating earnings per share growth expected to surpass the upper end of its 6% to 9% target range for 2026. The insurer reports GBP5.8 billion of pension risk transfer transactions in the nine months to September 30, compared with GBP5.9 billion a year earlier, rising to GBP6.7 billion including deals secured since the period end. Assets under management increase 4.0% year-on-year to GBP1.23 trillion, despite GBP28 billion of net outflows. Workplace net flows rise to GBP8.0 billion from GBP5.1 billion, while retail annuity sales increase 25% to GBP1.5 billion. Its solvency II coverage ratio improves to 213% from 201% at June 30. The group also expects to exceed GBP400 million of asset optimisation in 2026 and plans to reduce its workforce by around 1,000 roles by mid-2027.

----------

Coca-Cola HBC says the Johannesburg Stock Exchange has approved its secondary listing, with trading expected to begin next week Monday, ahead of the planned completion of its acquisition of Coca-Cola Beverages Africa next week Friday. The bottler says it has received merger approvals in five of six jurisdictions, with the transaction proceeding without implementation in Tanzania until regulatory clearance is secured. As part of the acquisition, Coca-Cola HBC will issue 21.0 million new shares to Gutsche Family Investments, representing 5.45% of its enlarged share capital. Following completion, Coca-Cola HBC expects to become the world's second-largest Coca-Cola bottler by volume, serving around 1.2 billion consumers. The company will retain its existing listings in London and Athens.

----------

AstraZeneca says its cancer treatment Imfinzi has been approved in the US for use in a perioperative regimen with enfortumab vedotin in patients with muscle-invasive bladder cancer. The approval follows results from the phase III Volga trial, which showed a 49% reduction in the risk of recurrence and a 42% reduction in the risk of death, with a manageable safety profile. Separately, AstraZeneca says its Klygefa treatment has received approval in both the US and EU for adults with generalised myasthenia gravis, a rare autoimmune disorder that causes severe muscle weakness.

----------

COMPANIES - FTSE 250

----------

Ceres Power Holdings signs a manufacturing licence agreement with an unnamed European energy technology company to produce its Ceres Endura solid oxide fuel cell technology across Europe, the Middle East and Africa. The non-exclusive agreement allows the partner to expand to a global licence by 2035, with plans to establish a manufacturing facility targeting capacity of around 200 megawatts. Ceres will receive upfront licence fees, engineering services revenue and future royalties from commercial production. The company expects to recognise revenue from the agreement in 2026 and now forecasts full-year revenue of around GBP60 million. Chief Executive Phil Caldwell says Ceres is optimistic about securing further manufacturing partnerships in the coming months.

----------

Grafton Group maintains its full-year adjusted operating profit guidance of GBP190 million to GBP200 million as trading momentum improves despite continued weakness in Great Britain. The construction materials distributor reports revenue growth of 7.4% to GBP2.29 billion in the year to October 31 from GBP2.13 billion a year earlier. Average daily like-for-like revenue growth accelerates to 2.0% in the four months to October 31 from 0.6% in the first half, supported by growth of 7.4% in Iberia and 6.5% in Ireland. However, like-for-like revenue in Great Britain declines 5.2% amid subdued construction and housebuilding activity. Grafton also confirms completion of its latest GBP25.0 million share buyback programme, bringing total repurchases since May 2022 to GBP478.3 million.

----------

Applied Nutrition reports a 44% rise in pretax profit to GBP41.0 million for the year ended July 31 from GBP28.5 million a year earlier, as revenue grows 51% to GBP161.6 million from GBP107.1 million. Adjusted pretax profit increases to GBP42.0 million from GBP30.2 million, while adjusted earnings before interest, tax, depreciation and amortisation rise 40% to GBP43.3 million from GBP30.9 million. Basic earnings per share increase to 12.2 pence from 8.4p. The sports nutrition company says strong trading momentum has continued into the first quarter of financial 2027, supported by market share gains and international expansion. Despite the strong start, it maintains current market expectations for the full year, citing the early stage of the financial period.

----------

OTHER COMPANIES

----------

Dar Global PLC announces plans for a new mixed-use development in Jeddah, Saudi Arabia, with an estimated gross development value of SAR1.0 billion, or USD267 million. The luxury property developer says it has acquired the land for around USD56 million, as part of a wider programme to expand its Saudi Arabian portfolio by up to SAR4.0 billion. The project will include luxury branded residences, with further details to be announced. Dar Global expects its global development pipeline to reach approximately USD24 billion following completion of the expansion programme. The company says further land acquisitions will be announced shortly, supported by strong demand from local and international buyers.

----------

H-Power launches its new 100-kilowatt hydrogen fuel cell generator, LC100dc, which is already operating under a revenue-generating contract at a major UK construction project. The hydrogen technology company says the initial deployment will consume up to 10,000 kilograms of green hydrogen and save more than 350 tonnes of carbon dioxide compared with a similarly sized diesel generator. The new unit delivers more than three times the power output of its existing LC30 generator at less than half the cost per kilowatt. H-Power says its joint venture with Speedy Hire has exceeded generator utilisation targets and secured a repeat order for 15 LC30 units, while customers are achieving cost parity with diesel on a weekly rental and fuel basis.

----------

By Eva Castanedo, Alliance News senior economics reporter

Comments and questions to [email protected]

Copyright 2026 Alliance News Ltd. All Rights Reserved.


Related Shares:

Coca-Cola HBCLegal & GeneralCeres PowerGrafton GroupAstrazenecaApplied Nutrition PLCH-powerCroda InternationalBellwayTravis PerkinsSpeedy Hire
FTSE 100 Latest
Value10,943.83
Change41.27